This is the authors' abstract. We don't add key points for this paper.
This first special issue of In Silico Pharmacology focuses on computational pharmacokinetics since they are an important part of integrated applications in computational pharmacology. The important topics of model structure, model parameterization, improved organ description, and modeling of drug-drug interactions are covered. They are actually at the crossroads between several emerging disciplines which will shape the future of therapeutic treatments and public health.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Frédéric Y. Bois (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: